Learn More
Medchemexpress LLC 1H-Pyrrole-2-carboxamide, N-(3-cyano-4-fluorophenyl)-1-methyl-4-[[[(1S)-2,2,2-trifluoro-1-methylethyl]amino]sulfonyl]- | 1638266-40-6 | 98.9% | 418.37 | 250 MG

Supplier: Medchemexpress LLC 250MGHY109168
Bersacapavir is an HBV capsid assembly modulator that exerts a dual mechanism of action against both early and late stages of HBV infection. It forms complete genome-free empty capsids and inhibits de novo synthesis of cccDNA, making it useful in hepatitis B research.
- Enhances the rate and extent of HBV capsid assembly.
- Potently inhibits HBV replication in HepG2.117 and HepG2.2.15 cells.
- Exhibits additive to synergistic antiviral activity when combined with TDF or ETV.
- Reduces extracellular HBV DNA, intracellular HBV RNA, extracellular HBe/cAg, and extracellular HBsAg.
- Inhibits cccDNA formation when added to HBV-infected PHHs.
- Disrupts pre-formed mature HBV capsids.
- Can be dissolved in 10% DMSO and 90% corn oil for in vivo dissolution.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.